Antibody targeting osteoclast-related protein Siglec-15
Details for Australian Patent Application No. 2008311698 (hide)
International Classifications
Event Publications
6 May 2010 PCT application entered the National Phase
PCT publication WO2009/048072 Priority application(s): WO2009/048072
1 December 2011 Application Accepted
Published as AU-B-2008311698
15 March 2012 Opposition Lodged
Alethia Biotherapeutics Inc. has lodged an opposition against Daiichi Sankyo Company, Limited.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2008311709-Hydrocarbon-reforming catalyst and process for producing synthesis gas using the same
2008311676-Method and kit for quantification of small, dense LDL cholesterol
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser